Concepts (125)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Glycopeptides | 14 | 2014 | 220 | 1.140 |
Why?
|
| Anti-Bacterial Agents | 16 | 2014 | 7408 | 0.350 |
Why?
|
| Staphylococcus aureus | 10 | 2013 | 1462 | 0.350 |
Why?
|
| Acculturation | 1 | 2009 | 177 | 0.300 |
Why?
|
| Family Relations | 1 | 2009 | 318 | 0.290 |
Why?
|
| Microbial Sensitivity Tests | 14 | 2014 | 1949 | 0.280 |
Why?
|
| Prodrugs | 4 | 2010 | 259 | 0.280 |
Why?
|
| Vancomycin | 5 | 2014 | 503 | 0.280 |
Why?
|
| Methicillin-Resistant Staphylococcus aureus | 4 | 2014 | 694 | 0.260 |
Why?
|
| Osteomyelitis | 4 | 2010 | 407 | 0.240 |
Why?
|
| Enterococcus | 3 | 2010 | 160 | 0.170 |
Why?
|
| Microbial Viability | 5 | 2014 | 238 | 0.160 |
Why?
|
| Daptomycin | 3 | 2014 | 71 | 0.150 |
Why?
|
| Poverty | 1 | 2009 | 2695 | 0.150 |
Why?
|
| Fluoroquinolones | 2 | 2008 | 308 | 0.140 |
Why?
|
| Serum Albumin | 2 | 2009 | 674 | 0.130 |
Why?
|
| Diphosphonates | 2 | 2010 | 638 | 0.120 |
Why?
|
| Methicillin Resistance | 1 | 2014 | 199 | 0.110 |
Why?
|
| Depression | 1 | 2009 | 8044 | 0.080 |
Why?
|
| Rifamycins | 1 | 2008 | 26 | 0.080 |
Why?
|
| Vancomycin Resistance | 1 | 2009 | 126 | 0.080 |
Why?
|
| Staphylococcal Infections | 4 | 2012 | 1407 | 0.080 |
Why?
|
| Enterococcus faecium | 1 | 2009 | 101 | 0.080 |
Why?
|
| Polysorbates | 1 | 2008 | 43 | 0.080 |
Why?
|
| Drug Resistance, Bacterial | 2 | 2013 | 1055 | 0.080 |
Why?
|
| Enterococcus faecalis | 1 | 2009 | 247 | 0.070 |
Why?
|
| Esters | 1 | 2008 | 211 | 0.070 |
Why?
|
| Streptococcus pyogenes | 1 | 2009 | 294 | 0.070 |
Why?
|
| Emigration and Immigration | 1 | 2009 | 395 | 0.070 |
Why?
|
| Community-Acquired Infections | 1 | 2009 | 461 | 0.060 |
Why?
|
| Blood Proteins | 1 | 2010 | 1173 | 0.060 |
Why?
|
| Social Environment | 1 | 2009 | 1022 | 0.060 |
Why?
|
| Molecular Structure | 4 | 2010 | 1895 | 0.060 |
Why?
|
| Triazines | 1 | 2005 | 310 | 0.060 |
Why?
|
| S-Adenosylmethionine | 1 | 2004 | 213 | 0.050 |
Why?
|
| Homocysteine | 1 | 2004 | 640 | 0.050 |
Why?
|
| Cell Membrane | 1 | 2010 | 3682 | 0.050 |
Why?
|
| Bacterial Proteins | 1 | 2014 | 3826 | 0.050 |
Why?
|
| DNA Helicases | 1 | 2005 | 854 | 0.040 |
Why?
|
| Estrogen Replacement Therapy | 1 | 2006 | 1206 | 0.040 |
Why?
|
| Linear Models | 1 | 2009 | 5877 | 0.040 |
Why?
|
| Estradiol | 1 | 2006 | 1932 | 0.040 |
Why?
|
| Adaptation, Psychological | 1 | 2009 | 2628 | 0.040 |
Why?
|
| Family | 1 | 2009 | 3189 | 0.040 |
Why?
|
| Massachusetts | 1 | 2009 | 8803 | 0.030 |
Why?
|
| Models, Biological | 1 | 2012 | 9467 | 0.030 |
Why?
|
| Rats | 5 | 2010 | 23711 | 0.030 |
Why?
|
| Sex Factors | 1 | 2009 | 10547 | 0.030 |
Why?
|
| Stress, Psychological | 1 | 2009 | 4446 | 0.030 |
Why?
|
| Oxazolidinones | 1 | 2014 | 97 | 0.030 |
Why?
|
| Mental Disorders | 1 | 2012 | 6796 | 0.030 |
Why?
|
| Acetamides | 1 | 2014 | 256 | 0.030 |
Why?
|
| Staphylococcal Skin Infections | 1 | 2013 | 78 | 0.030 |
Why?
|
| Drug Dosage Calculations | 1 | 2012 | 118 | 0.030 |
Why?
|
| Colony Count, Microbial | 1 | 2012 | 328 | 0.030 |
Why?
|
| Infusion Pumps | 1 | 2012 | 163 | 0.020 |
Why?
|
| Structure-Activity Relationship | 2 | 2008 | 3084 | 0.020 |
Why?
|
| Culture Media | 1 | 2012 | 900 | 0.020 |
Why?
|
| Cephalosporins | 1 | 2010 | 204 | 0.020 |
Why?
|
| Bacterial Typing Techniques | 1 | 2009 | 260 | 0.020 |
Why?
|
| Cognition | 1 | 2006 | 6957 | 0.020 |
Why?
|
| Clinical Trials, Phase III as Topic | 1 | 2012 | 861 | 0.020 |
Why?
|
| Area Under Curve | 1 | 2012 | 1636 | 0.020 |
Why?
|
| Teicoplanin | 1 | 2008 | 27 | 0.020 |
Why?
|
| Humans | 17 | 2013 | 760621 | 0.020 |
Why?
|
| Time Factors | 4 | 2011 | 40165 | 0.020 |
Why?
|
| Adsorption | 1 | 2008 | 198 | 0.020 |
Why?
|
| Radioligand Assay | 1 | 2008 | 366 | 0.020 |
Why?
|
| Staphylococcus | 1 | 2008 | 156 | 0.020 |
Why?
|
| Streptococcus | 1 | 2008 | 198 | 0.020 |
Why?
|
| Protein Binding | 2 | 2010 | 9335 | 0.020 |
Why?
|
| Horses | 1 | 2008 | 298 | 0.020 |
Why?
|
| Amines | 1 | 2008 | 281 | 0.020 |
Why?
|
| Carbon Radioisotopes | 1 | 2008 | 557 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2009 | 10827 | 0.020 |
Why?
|
| Young Adult | 2 | 2012 | 58741 | 0.020 |
Why?
|
| Culture Media, Conditioned | 1 | 2008 | 522 | 0.020 |
Why?
|
| Gram-Positive Bacterial Infections | 1 | 2009 | 343 | 0.020 |
Why?
|
| Amination | 1 | 2005 | 18 | 0.020 |
Why?
|
| Species Specificity | 1 | 2010 | 2418 | 0.020 |
Why?
|
| Genes, Bacterial | 1 | 2009 | 1071 | 0.020 |
Why?
|
| Exercise Therapy | 1 | 2012 | 919 | 0.020 |
Why?
|
| Dogs | 1 | 2010 | 3841 | 0.020 |
Why?
|
| Formates | 1 | 2004 | 40 | 0.020 |
Why?
|
| Streptococcal Infections | 1 | 2009 | 617 | 0.020 |
Why?
|
| Perimenopause | 1 | 2006 | 141 | 0.020 |
Why?
|
| Surface Properties | 1 | 2008 | 1161 | 0.020 |
Why?
|
| Educational Status | 1 | 2012 | 2515 | 0.020 |
Why?
|
| Animals | 7 | 2010 | 167963 | 0.010 |
Why?
|
| Outpatients | 1 | 2012 | 1607 | 0.010 |
Why?
|
| Analysis of Variance | 1 | 2012 | 6238 | 0.010 |
Why?
|
| Biological Availability | 1 | 2004 | 395 | 0.010 |
Why?
|
| Administration, Cutaneous | 1 | 2006 | 713 | 0.010 |
Why?
|
| Hot Flashes | 1 | 2006 | 328 | 0.010 |
Why?
|
| Cell Line | 2 | 2008 | 15620 | 0.010 |
Why?
|
| Formaldehyde | 1 | 2004 | 358 | 0.010 |
Why?
|
| Adult | 4 | 2012 | 219994 | 0.010 |
Why?
|
| Bone Density Conservation Agents | 1 | 2010 | 796 | 0.010 |
Why?
|
| Feasibility Studies | 1 | 2012 | 5201 | 0.010 |
Why?
|
| Female | 6 | 2012 | 391270 | 0.010 |
Why?
|
| Gene Expression | 1 | 2014 | 7588 | 0.010 |
Why?
|
| Middle Aged | 3 | 2012 | 220352 | 0.010 |
Why?
|
| Bacterial Infections | 1 | 2008 | 1403 | 0.010 |
Why?
|
| Sleep Deprivation | 1 | 2006 | 840 | 0.010 |
Why?
|
| Pseudomonas aeruginosa | 1 | 2005 | 1276 | 0.010 |
Why?
|
| Male | 3 | 2012 | 359744 | 0.010 |
Why?
|
| Postmenopause | 1 | 2006 | 2509 | 0.010 |
Why?
|
| Aged | 1 | 2009 | 169152 | 0.010 |
Why?
|
| Administration, Oral | 1 | 2004 | 4035 | 0.010 |
Why?
|
| Prefrontal Cortex | 1 | 2006 | 2212 | 0.010 |
Why?
|
| Enzyme Inhibitors | 1 | 2005 | 3726 | 0.010 |
Why?
|
| Genotype | 1 | 2009 | 12960 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 2012 | 22053 | 0.010 |
Why?
|
| Severity of Illness Index | 1 | 2012 | 15840 | 0.010 |
Why?
|
| Genetic Variation | 1 | 2009 | 6551 | 0.010 |
Why?
|
| Escherichia coli | 1 | 2005 | 4219 | 0.010 |
Why?
|
| Neuropsychological Tests | 1 | 2006 | 7021 | 0.010 |
Why?
|
| Mice | 2 | 2010 | 81208 | 0.010 |
Why?
|
| Treatment Outcome | 2 | 2012 | 65017 | 0.010 |
Why?
|
| Double-Blind Method | 1 | 2006 | 12427 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2008 | 18137 | 0.010 |
Why?
|
| Bipolar Disorder | 1 | 2004 | 5078 | 0.000 |
Why?
|
| Risk Factors | 1 | 2012 | 74359 | 0.000 |
Why?
|
| Adolescent | 1 | 2012 | 87810 | 0.000 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2006 | 36290 | 0.000 |
Why?
|
Concepts
(125)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(7)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_